Gretel Major

Ms. Gretel Major

University of Otago, Christchurch
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2020 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
ZEZehra Elgundi
Zehra Elgundi
MPMichael Papanicolaou
Michael Papanicolaou
Gretel MajorGretel Major
Gretel Major
TCThomas R. Cox
Thomas R. Cox
JMJames Melrose
James Melrose
Brooke FarrugiaBrooke Farrugia
Brooke Farrugia
Cancer metastasis is the dissemination of tumor cells to new sites, resulting in the formation of secondary tumors. This process is complex and is spatially and temporally regulated by intrinsic and extrinsic factors. One important extrinsic factor is the extracellular matrix, the non-cellular component of tissues. Heparan sulfate proteoglycans (HSPGs) are constituents of the extracellular matrix, and through their heparan sulfate chains and protein core, modulate multiple events that occur during the metastatic cascade. This review will provide an overview of the role of the extracellular matrix in the events that occur during cancer metastasis, primarily focusing on perlecan. Perlecan, a basement membrane HSPG is a key component of the vascular extracellular matrix and is commonly associated with events that occur during the metastatic cascade. Its contradictory role in these events will be discussed and we will highlight the recent advances in cancer therapies that target HSPGs and their modifying enzymes.

28 August 2023 in Nature Cancer
Verified
Journal Article
Open access
PDF file
JCJessica Chitty
Jessica Chitty
MYMichelle Yam
Michelle Yam
LPLara Perryman
Lara Perryman
APAmelia L. Parker
Amelia L. Parker
JSJoanna N. Skhinas
Joanna N. Skhinas
TCThomas R. Cox
Thomas R. Cox
The lysyl oxidase family represents a promising target in stromal targeting of solid tumors due to the importance of this family in crosslinking and stabilizing fibrillar collagens and its known role in tumor desmoplasia. Using small-molecule drug-design approaches, we generated and validated PXS-5505, a first-in-class highly selective and potent pan-lysyl oxidase inhibitor. We demonstrate in vitro and in vivo that pan-lysyl oxidase inhibition decreases chemotherapy-induced pancreatic tumor desmoplasia and stiffness, reduces cancer cell invasion and metastasis, improves tumor perfusion and enhances the efficacy of chemotherapy in the autochthonous genetically engineered KPC model, while also demonstrating antifibrotic effects in human patient-derived xenograft models of pancreatic cancer. PXS-5505 is orally bioavailable, safe and effective at inhibiting lysyl oxidase activity in tissues. Our findings present the rationale for progression of a pan-lysyl oxidase inhibitor aimed at eliciting a reduction in stromal matrix to potentiate chemotherapy in pancreatic ductal adenocarcinoma.

28 October 2021 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
PDF file
BSBram G. Soliman
Bram G. Soliman
Gretel MajorGretel Major
Gretel Major
PAPau Atienza‐Roca
Pau Atienza‐Roca
CMCaroline A. Murphy
Caroline A. Murphy
ALAlessia Longoni
Alessia Longoni
Khoon LimKhoon Lim
Khoon Lim

1 October 2021 in Science Advances
Verified
Journal Article
Open access
KMKendelle J. Murphy
Kendelle J. Murphy
DRDaniel A. Reed
Daniel A. Reed
CVClaire Vennin
Claire Vennin
JCJames Conway
James Conway
Max NobisMax Nobis
Max Nobis
PTPaul Timpson
Paul Timpson
Intravital imaging guides a personalized medicine approach to target mechanoreciprocity in pancreatic cancer.

16 February 2024 in Materials Today Bio
Verified
Journal Article
Open access
Gretel MajorGretel Major
Gretel Major
MAMinjun Ahn
Minjun Ahn
WCWon-Woo Cho
Won-Woo Cho
MSMiguel Santos
Miguel Santos
JWJessika Wise
Jessika Wise
Khoon LimKhoon Lim
Khoon Lim
Extracellular matrix (ECM) stiffening is a common occurrence during the progression of many diseases, such as breast cancer. To accurately mimic the pathophysiological context of disease within 3D in vitro models, there is high demand for smart biomaterials which replicate the dynamic and temporal mechanical cues of diseased states. This study describes a preclinical disease model, using breast cancer as an example, which replicates the dynamic plasticity of the tumour microenvironment by incorporating temporal (3-week progression) biomechanical cues within a tissue-specific hydrogel microenvironment. The composite hydrogel formulation, integrating adipose-derived decellularised ECM (AdECM) and silk fibroin, was initially crosslinked using a visible light-mediated system, and then progressively stiffened through spontaneous secondary structure interactions inherent between the polymer chains (∼10–15 kPa increase, with a final stiffness of 25 kPa). When encapsulated and cultured in vitro, MCF-7 breast cancer cells initially formed numerous, large spheroids (>1000 μm2 in area), however, with progressive temporal stiffening, cells demonstrated growth arrest and underwent phenotypic changes resulting in intratumoral heterogeneity. Unlike widely-investigated static mechanical models, this stiffening hydrogel allowed for progressive phenotypic changes to be observed, and fostered the development of mature organoid-like spheroids, which mimicked both the organisation and acinar-structures of mature breast epithelium. The spheroids contained a central population of cells which expressed aggressive cellular programs, evidenced by increased fibronectin expression and reduction of E-cadherin. The phenotypic heterogeneity observed using this model is more reflective of physiological tumours, demonstrating the importance of establishing temporal cues within preclinical models in future work. Overall, the developed model demonstrated a novel strategy to uncouple ECM biomechanical properties from the cellular complexities of the disease microenvironment and offers the potential for wide applicability in other 3D in vitro disease models through addition of tissue-specific dECM materials.

5 February 2024 in Trends in Biotechnology
Verified
Journal Article
Closed access
Gretel MajorGretel Major
Gretel Major
VDVinh K. Doan
Vinh K. Doan
ALAlessia Longoni
Alessia Longoni
MBMarcela M.M. Bilek
Marcela M.M. Bilek
SWSteven Wise
Steven Wise
Khoon LimKhoon Lim
Khoon Lim